XML 31 R21.htm IDEA: XBRL DOCUMENT v3.25.3
STOCKHOLDERS' EQUITY
 9 Months Ended
Sep. 30, 2025
Stockholders' Equity Note [Abstract]  
STOCKHOLDERS’ EQUITY STOCKHOLDERS’ EQUITY
The following table presents the number of shares authorized and issued as of September 30, 2025 and December 31, 2024 (in thousands):
September 30, 2025December 31, 2024
Shares
Authorized
Shares
Issued
Shares
Authorized
Shares
Issued
Common stock, $0.000001 par value
200,000 62,141 200,000 65,792 
Undesignated preferred stock10,000 — 10,000 — 
Stock Repurchase Program
As of September 30, 2025, the Company’s board of directors had authorized the Company to repurchase up to an aggregate of $1.95 billion of its outstanding common stock, $127.3 million of which remained available as of September 30, 2025. The Company may purchase shares at management’s discretion in the open market, in privately negotiated transactions, in transactions structured through investment banking institutions or a combination of the foregoing.
During the nine months ended September 30, 2025, the Company repurchased on the open market 5,843,952 shares for an aggregate purchase price of $203.4 million and retired 5,862,680 shares. As of September 30, 2025, the Company had a treasury stock balance of 82,132 shares, which were excluded from its outstanding share count as of such date and subsequently retired in October 2025.
During the nine months ended September 30, 2024, the Company repurchased on the open market 4,979,329 shares for an aggregate purchase price of $188.4 million and retired 4,895,875 shares. As of September 30, 2024, the Company had a treasury stock balance of 83,454 shares, which were excluded from its outstanding share count as of such date and subsequently retired in October 2024.
Equity Incentive Plans
Stock Options
A summary of stock option activity for the nine months ended September 30, 2025 is as follows:
Number of Shares (in thousands)Weighted-Average Exercise PriceWeighted-Average Remaining Contractual Term (in years)Aggregate Intrinsic Value (in thousands)
Outstanding at December 31, 20242,464 $34.44 2.6$14,407 
Exercised(42)20.86  
Canceled(144)50.36 
Outstanding at September 30, 20252,278 $33.69 2.0$5,035 
Options vested and exercisable at September 30, 20252,278 $33.69 2.0$5,035 
RSUs
RSUs include PRSUs that are subject to either (a) a market condition or (b) the achievement of performance goals. As the PRSU activity during the nine months ended September 30, 2025 was not material, it is presented together with the RSU activity in the table below. A summary of RSU and PRSU activity for the nine months ended September 30, 2025 is as follows (in thousands, except per share amounts):
Number of SharesWeighted-Average Grant Date Fair Value
Nonvested at December 31, 20246,715 $36.10 
Granted2,720 40.73 
Vested(1)
(3,135)36.31 
Canceled(445)36.72 
Nonvested at September 30, 2025(2)
5,855 $38.09 
(1)    Includes 1,316,991 shares that vested but were not issued due to the Company’s use of net share settlement for payment of employee taxes.
(2)    Includes 833,587 PRSUs.
The aggregate fair value as of the vest date of RSUs and PRSUs that vested during the nine months ended September 30, 2025 and 2024 was $111.5 million and $139.8 million, respectively. As of September 30, 2025, the Company had approximately $190.3 million of unrecognized stock-based compensation expense related to RSUs and PRSUs, which it expects to recognize over the remaining weighted-average vesting period of approximately 1.9 years.
Employee Stock Purchase Plan
There were no shares purchased by employees under the Employee Stock Purchase Plan (“ESPP”) during the three months ended September 30, 2025 and 2024. There were 351,911 shares purchased by employees under the ESPP at a weighted-average purchase price of $32.44 per share during the nine months ended September 30, 2025. There were 387,968 shares purchased by employees under the ESPP at a weighted-average purchase price of $31.42 per share during the nine months ended September 30, 2024. The Company recognized stock-based compensation expense related to the ESPP of $0.9 million and $0.8 million during the three months ended September 30, 2025 and 2024, respectively, and $2.9 million and $2.8 million during the nine months ended September 30, 2025 and 2024, respectively.
Stock-Based Compensation
The following table summarizes the effects of stock-based compensation expense related to stock-based awards in the condensed consolidated statements of operations during the periods presented (in thousands):
Three Months Ended
September 30,		Nine Months Ended
September 30,
2025202420252024
Cost of revenue$997 $1,301 $3,238 $4,099 
Sales and marketing7,052 8,588 21,986 25,905 
Product development16,607 20,887 53,862 67,074 
General and administrative8,225 8,696 26,039 26,318 
Total stock-based compensation recorded to income before income taxes32,881 39,472 105,125 123,396 
Benefit from income taxes(6,582)(7,560)(21,001)(24,015)
Total stock-based compensation recorded to net income attributable to common stockholders$26,299 $31,912 $84,124 $99,381 
The Company capitalized $3.0 million and $3.3 million of stock-based compensation expense as website and internal-use software development costs and, to a lesser extent, implementation costs incurred related to cloud computing arrangements that are service contracts in the three months ended September 30, 2025 and 2024, respectively, and $8.8 million and $9.2 million in the nine months ended September 30, 2025 and 2024, respectively.